Growth Metrics

Insulet (PODD) Cash from Operations Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -7.20%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 132.40%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 6.69%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -35.67%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -84.38%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 122.43%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 185.96%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 16.00%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 28.60%
10 Insulet 10.37 Bn 9.89 Bn 529.10 Mn 78.37%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 78.37%
Dec 31, 2025 24.27%
Sep 30, 2025 16.07%
Jun 30, 2025 126.38%
Mar 31, 2025 -27.17%
Dec 31, 2024 226.33%
Sep 30, 2024 93.39%
Jun 30, 2024 97.27%
Mar 31, 2024 17,420.00%
Dec 31, 2023 -10.85%
Sep 30, 2023 -1.23%
Jun 30, 2023 73.91%
Mar 31, 2023 103.65%
Dec 31, 2022 298.82%
Sep 30, 2022 319.77%
Jun 30, 2022 38.25%
Mar 31, 2022 60.97%
Dec 31, 2021 -250.00%
Sep 30, 2021 -158.37%
Jun 30, 2021 -30.68%
Mar 31, 2021 -875.00%
Dec 31, 2020 -63.75%
Sep 30, 2020 42.12%
Jun 30, 2020 89.93%
Mar 31, 2020 -155.38%
Dec 31, 2019 54.07%
Sep 30, 2019 96.15%
Jun 30, 2019 326.79%
Mar 31, 2019 252.37%
Dec 31, 2018 39.04%
Sep 30, 2018 -31.89%
Jun 30, 2018 -134.12%
Mar 31, 2018 80.46%
Dec 31, 2017 9.08%
Sep 30, 2017 769.56%
Jun 30, 2017 388.02%
Mar 31, 2017 -107.62%
Dec 31, 2016 207.93%
Sep 30, 2016 -69.39%
Jun 30, 2016 368.92%
Mar 31, 2016 -201.52%
Dec 31, 2015 -503.62%
Sep 30, 2015 81.38%
Jun 30, 2015 54.53%
Mar 31, 2015 -242.97%
Dec 31, 2014 230.96%
Sep 30, 2014 30.54%
Jun 30, 2014 -88.38%
Mar 31, 2014 15.25%
Dec 31, 2013 37.10%
Sep 30, 2013 207.10%
Jun 30, 2013 139.34%
Mar 31, 2013 86.52%
Dec 31, 2012 27.06%
Sep 30, 2012 -312.56%
Jun 30, 2012 -22.37%
Mar 31, 2012 -13.18%
Dec 31, 2011 0.45%
Sep 30, 2011 93.50%